Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PRH1-PRR4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MUC5AC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIAA1211L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERICH1-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
CD4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PAX4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
SYNGR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CA6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNF212B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC441601 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATP6V1H - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CRISP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM13A-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IDO2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAPT-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DAO - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LPAR6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on